Sign in
4

Changes in Ownership

Armata Pharmaceuticals, Inc. Filed Acc 0001144204-19-028260

Options or other derivatives

  • Chief Financial Officer acquired 149,362 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Martin Steven Robert Chief Financial Officer 2019-05-22 Grant or award · Stock Option (Right to Buy) +149,362 149,362 D
Loading xslF345X03/tv522367_4.xml…